Berlin, Germany

Mario Kennekke


Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mario Kennekke in Steroid Production

Introduction

Mario Kennekke, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of steroid production. With a total of two patents to his name, Kennekke has demonstrated a commitment to advancing scientific methods and enhancing industrial processes.

Latest Patents

Kennekke's latest patents include a unique process for the production of 17-oxosteroids through fermentative oxidation. This innovative method utilizes specific bacterial cultures from species such as Mycobacterium spec. NRRL B-3805, Mycobacterium spec. NRRL B-3683, Mycobacterium phlei NRRL B-8154, and Mycobacterium fortuitum NRRL B-8153, showcasing his expertise in biological applications for steroid synthesis. Additionally, he holds a patent for the production of 20-methyl-5,7-pregnadiene-3.beta.,21-diol, which reflects his ongoing research in this critical area.

Career Highlights

Mario Kennekke is currently employed at Schering Aktiengesellschaft, a leading company known for its contributions to pharmaceuticals and biotechnology. His career has been marked by his dedication to research and development, paving the way for new methodologies in steroid production that enhance efficiency and effectiveness in the industry.

Collaborations

Kennekke collaborates with esteemed colleagues in his field, including Alfred Weber and Uwe Klages. Their combined expertise fosters a rich environment for innovation, allowing for the exploration of new ideas and solidifying their contributions to the scientific community.

Conclusion

In conclusion, Mario Kennekke stands out as a notable inventor in the area of steroid production, with a clear focus on utilizing innovative fermentation processes. His patents not only reflect his technical skills but also his commitment to advancing the pharmaceutical industry, making a lasting impact through his work at Schering Aktiengesellschaft and in collaboration with his peers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…